Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1976 Jan;13(1):127–132. doi: 10.1128/iai.13.1.127-132.1976

Effect of rifampin on immunity to tuberculosis and on delayed hypersensitivity to purified protein derivative.

A S Youmans, G P Youmans, D Cahall
PMCID: PMC420586  PMID: 814098

Abstract

Mice vaccinated with mycobacterial ribonucleic acid (RNA) produced a high immune response and did not develop delayed hypersensitivity to purified protein derivative (PPD), and rifampin had no effect on the immune response. Mice vaccinated with viable H37Ra cells produced a high immune response and did develop delayed hypersensitivity to PPD. Rifampin had no effect on this immune response, but reduced the footpad reactions to PPD. Both mycobacterial RNA and poly(A:U) served as adjuvants for induction of hypersensitivity to PPD. This hypersensitivity was reduced by the administration of rifampin. Rifampin had no effect on the production of mycobacterial growth inhibitory factor, which is produced following vaccination of mice with mycobacterial RNA or viable H37Ra cells. Rifampin had no effect on the nonspecific phase of the granulomatous response, but did inhibit the secondary allergic phase of this response. The action, therefore, of rifampin that inhibits the induction of delayed hypersensitivity but had no effect on the immune responses against tuberculosis leads to a separation of tuberculin hypersensitivity from cellular immunity to tuberculosis.

Full text

PDF
127

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bassi L., Di Berardino L., Arioli V., Silvestri L. G., Lignière E. L. Conditions for immunosuppression by rifampicin. J Infect Dis. 1973 Dec;128(6):736–744. doi: 10.1093/infdis/128.6.736. [DOI] [PubMed] [Google Scholar]
  2. Casavant C. H., Youmans G. P. The adjuvant activity of mycobacterial RNA preparations and synthetic polynucleotides for induction of delayed hypersensitivity to purified protein derivative in guinea pigs. J Immunol. 1975 Mar;114(3):1014–1022. [PubMed] [Google Scholar]
  3. Grassi G. G., Pozzi E. Effect of rifampicin on delayed-hypersensitivity reactions. J Infect Dis. 1972 Nov;126(5):542–544. doi: 10.1093/infdis/126.5.542. [DOI] [PubMed] [Google Scholar]
  4. Jones T., Youmans G. P. The in vitro inhibition of growth of intracellular Listeria monocytogenes by lymphocyte products. Cell Immunol. 1973 Dec;9(3):353–362. doi: 10.1016/0008-8749(73)90050-6. [DOI] [PubMed] [Google Scholar]
  5. KANAI K., YOUMANS G. P., YOUMANS A. S. Allergenicity of intracellular particles, cell walls, and cytoplasmic fluid from Mycobacterium tuberculosis. J Bacteriol. 1960 Nov;80:615–621. doi: 10.1128/jb.80.5.615-621.1960. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Klun C. L., Youmans G. P. The effect of lymphocyte supernatant fluids on the intracellular growth of virulent tubercle bacilli. J Reticuloendothel Soc. 1973 Mar;13(3):263–274. [PubMed] [Google Scholar]
  7. Klun C. L., Youmans G. P. The induction by Listeria monocytogenes and plant mitogens of lymphocyte supernatant fluids which inhibit the growth of Mycobacterium tuberculosis within macrophages in vitro. J Reticuloendothel Soc. 1973 Mar;13(3):275–285. [PubMed] [Google Scholar]
  8. Lefford M. J., McGregor D. D. The effect of chemotherapy for tuberculosis on immunity to tuberculosis. J Infect Dis. 1974 Apr;129(4):473–476. doi: 10.1093/infdis/129.4.473. [DOI] [PubMed] [Google Scholar]
  9. Lester W. Rifampin: a semisynthetic derivative of rifamycin--a prototype for the future. Annu Rev Microbiol. 1972;26:85–102. doi: 10.1146/annurev.mi.26.100172.000505. [DOI] [PubMed] [Google Scholar]
  10. Patterson R. J., Youmans G. P. Demonstration in tissue culture of lymphocyte-mediated immunity to tuberculosis. Infect Immun. 1970 Jun;1(6):600–603. doi: 10.1128/iai.1.6.600-603.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. YOUMANS G. P., YOUMANS A. S. AN ACUTE PULMONARY GRANULOMATOUS RESPONSE IN MICE PRODUCED BY MYCOBACTERIAL CELLS AND ITS RELATION TO INCREASED RESISTANCE AND INCREASED SUSCEPTIBILITY TO EXPERIMENTAL TUBERCULOUS INFECTION. J Infect Dis. 1964 Apr;114:135–151. doi: 10.1093/infdis/114.2.135. [DOI] [PubMed] [Google Scholar]
  12. YOUMANS G. P., YOUMANS A. S. The measurement of the response of immunized mice to infection with Mycobacterium tuberculosis va. hominis. J Immunol. 1957 May;78(5):318–329. [PubMed] [Google Scholar]
  13. Youmans A. S., Youmans G. P. Factors affecting immunogenic activity of mycobacterial ribosomal and ribonucleic acid preparations. J Bacteriol. 1969 Jul;99(1):42–50. doi: 10.1128/jb.99.1.42-50.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Youmans A. S., Youmans G. P. Immunogenic mycobacterial ribosomal and ribonucleic Acid preparations: chemical and physical characteristics. Infect Immun. 1970 Nov;2(5):659–668. doi: 10.1128/iai.2.5.659-668.1970. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Youmans A. S., Youmans G. P. Preparation and effect of different adjuvants on the immunogenic activity of mycobacterial ribosomal fraction. J Bacteriol. 1967 Oct;94(4):836–843. doi: 10.1128/jb.94.4.836-843.1967. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Youmans A. S., Youmans G. P. Preparation of highly immunogenic ribosomal fractions of Mycobacterium tuberculosis by use of sodium dodecyl sulfate. J Bacteriol. 1966 Jun;91(6):2139–2145. doi: 10.1128/jb.91.6.2139-2145.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Youmans A. S., Youmans G. P. Ribonucleic acid, deoxyribonucleic acid, and protein content of cells of different ages of Mycobacterium tuberculosis and the ralationship to immunogenicity. J Bacteriol. 1968 Feb;95(2):272–279. doi: 10.1128/jb.95.2.272-279.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Youmans A. S., Youmans G. P. The effect of metabolic inhibitors and hydroxylamine on the immune response in mice to mycobacterial ribonucleic acid vaccines. J Immunol. 1974 Jan;112(1):271–284. [PubMed] [Google Scholar]
  19. Youmans G. P. Relation between delayed hypersensitivity and immunity in tuberculosis. Am Rev Respir Dis. 1975 Feb;111(2):109–118. doi: 10.1164/arrd.1975.111.2.109. [DOI] [PubMed] [Google Scholar]
  20. Youmans G. P., Youmans A. S. Allergenicity of mycobacterial ribosomal and ribonucleic acid preparations in mice and guinea pigs. J Bacteriol. 1969 Jan;97(1):134–139. doi: 10.1128/jb.97.1.134-139.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Youmans G. P., Youmans A. S. Immunizing capacity of viable and killed attenuated mycobacterial cells against experimental tuberculous infection. J Bacteriol. 1969 Jan;97(1):107–113. doi: 10.1128/jb.97.1.107-113.1969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Youmans G. P., Youmans A. S. The effect of mycobacterial RNA on the primary antibody response of mice to bovine globulin. J Immunol. 1972 Aug;109(2):217–221. [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES